Medical Learning Company (MLC) has announced it expects to receive $1.75 million from the Army’s Telemedicine Advanced Technology Research Center to further develop SynPatient online patient simulation training software.

The goal is to enhance the military’s ability to rapidly train and prepare medical care-team personnel for biological and chemical warfare.

Headed by CEO Ray Kurzweil, MLC is a joint venture between Kurzweil Technologies Inc. and the American Board of Family Practice (ABFP). It plans to work with the Army to include medical cases from all infectious disease agents and toxins within the CDC Category A and B classifications, chemical agents, and nuclear material-related events; and to support inoculation training programs.

MLC’s strategy is to broadly distribute Kurzweil Simulation Technology (KST), and SynPatient as a core technology to revolutionize healthcare education and training in today’s distance-learning environment.